R. Coldewey

发表

Malnutrition and immune dysfunction in patients infected with Human Immunodeficiency Virus

U. Süttmann, J. Ockenga, L. Hoogestraat, 1991, Klinische Wochenschrift.

Major Histocompatibility Complex Haplotypes and Complement C 4 Alleles in Systemic Lupus Erythematosus Results of a Multicenter Study

Susanne, J., P. Schneider, 2013 .

Complement split product C3d as an indicator of disease activity in systemic lupus erythematosus

H. Peter, B. Lang, E. Röther, 1993, Clinical Rheumatology.

Immunoglobulin allotypes are not associated with HLA-antigens, autoantibodies and clinical symptoms in systemic lupus erythematosus

W. Stangel, C. Specker, G. G. Lange, 2004, Rheumatology International.

MHC associations of autoantibodies against recombinant Ro and La proteins in systemic lupus erythematosus

H. Peter, J. Kalden, M. Renz, 1992, Rheumatology International.

Treatment of Gram-Negative Septic Toxic Diseases with an Immunoglobulin Preparation Containing IgG, IgM and IgA: A Prospective Randomized Clinical Trial

I. Schedel, H. Deicher, R. Coldewey, 1993 .

A comparison of polychemotherapy and melphalan/prednisone for primary remission induction, and interferon-alpha for maintenance treatment, in multiple myeloma. A prospective trial of the German Myeloma Treatment Group.

H. Deicher, M. Petit, R. Bartl, 1995, European journal of cancer.

Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study.

P. Schneider, H. Peter, J. Kalden, 1992, The Journal of clinical investigation.

Induction and maintenance therapy in multiple myeloma: a multicenter trial of MP versus VCMP.

I. Schedel, H. Deicher, H. Schmoll, 1988, European journal of cancer & clinical oncology.

MHC gene products and anticardiolipin antibodies in systemic lupus erythematosus results of a multicenter study. SLE Study Group.

H. Peter, J. Kalden, H. Deicher, 1992, Autoimmunity.

Study of platelet-associated immunoglobulins of IgG, IgM, IgA, and IgE classes and platelet kinetics in 33 patients with idiopathic thrombocytopenic purpura

H. Deicher, R. Coldewey, S. Blanc, 1994, Annals of Hematology.

Immunotherapy in sepsis

D. Angus, P. Speelman, M. Pinsky, 1992, Intensive Care Medicine.

Hetero- and homozygosity of MHC class II gene products in systemic lupus erythematosus. The Members of the Deutsche Multizentrische SLE-Studie.

P. Schneider, W. Stangel, S. Seuchter, 1991, Tissue antigens.

Prognostic relevance of a histologic classification system applied in bone marrow biopsies from patients with multiple myeloma: A histopathological evaluation of biopsies from 153 untreated patients *

H. Deicher, H. Deicher, A. Georgii, 1995, European journal of haematology.

Prognostic value of clinical, laboratory, and histological characteristics in multiple myeloma: improved definition of risk groups.

V. Diehl, H. Deicher, A. Georgii, 1993, European journal of cancer.

The genetic basis of Ro and La antibody formation in systemic lupus erythematosus

H. Seelig, H. Ehrfeld, H. Deicher, 1992, Rheumatology International.

Melphalan and prednisone (MP) versus vincristine, BCNU, adriamycin, melphalan and dexamethasone (VBAMDex) therapy for multiple myeloma. Early results of a multicenter trial. The German Myeloma Treatment Group.

R. Hein, H. Deicher, E. Kreuser, 1990, Onkologie.

Melphalan and prednisone (MP) versus vincristine, BCNU, adriamycin, melphalan and dexamethasone (VBAM Dex) induction chemotherapy and interferon maintenance treatment in multiple myeloma. Current results of a multicenter trial. The German Myeloma Treatment Group.

H. Deicher, M. Gramatzki, R. Bartl, 1990, Onkologie.